TAP
57
6
ED
39
8
AMP
43
2
CNX
67
4
ROST
60
3
GOOG
77
14
IBM
53
2
HST
53
4
LMT
29
-5
LUV
45
3
CME
59
3
STX
34
2
BMY
40
-5
NRG
32
5
AON
25
4
GD
42
4
VRSK
54
2
NWS
69
5
MSI
52
3
EBAY
42
2
TAP
57
6
ED
39
8
AMP
43
2
CNX
67
4
ROST
60
3
GOOG
77
14
IBM
53
2
HST
53
4
LMT
29
-5
LUV
45
3
CME
59
3
STX
34
2
BMY
40
-5
NRG
32
5
AON
25
4
GD
42
4
VRSK
54
2
NWS
69
5
MSI
52
3
EBAY
42
2
Financhill
Back

Sarepta Therapeutics Vs. Smith-Midland Industry Stock Comparison

Sell
36

SRPT
Sarepta Therapeutics

Last Price:
$118.99
Seasonality Move:
12.18%
Buy
63

SMID
Smith-Midland

Last Price:
$42.90
Seasonality Move:
8.35%
Sell
36
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $118.97. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
63
Smith-Midland (SMID) is a Buy

Is Smith-Midland a Buy, Sell or Hold?

  • The current Smith-Midland [SMID] share price is $43.13. The Score for SMID is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • SMID is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $118.97
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

SMID Stock Price Chart

What is Smith-Midland's stock price today?

  • The Smith-Midland share price today is $43.13
    The current trend is moderately bearish and SMID is experiencing slight selling pressure.

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 43.28 Sell
Chaikin Money Flow: -1117882 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (112.92 - 130.54) Sell
Bollinger Bands (100): (118.37 - 135.77) Sell

SMID Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.2 Buy
Relative Strength Index (14 RSI): 46.04 Sell
Chaikin Money Flow: -16720 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.57 - 49.09) Sell
Bollinger Bands (100): (30.44 - 42.74) Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 123.1 Sell
20-day SMA: 125.31 Sell
50-day SMA: 122.99 Sell
200-day SMA: 129.64 Sell
8-day EMA: 122.43 Sell
20-day EMA: 123.17 Sell
50-day EMA: 123.7 Sell
200-day EMA: 126 Sell

SMID Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.55 Sell
20-day SMA: 47.33 Sell
50-day SMA: 40.37 Buy
200-day SMA: 36.14 Buy
8-day EMA: 45.67 Sell
20-day EMA: 45.58 Sell
50-day EMA: 41.99 Buy
200-day EMA: 36.21 Buy

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.79 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.75 per share, and an increase next year of $7.84 per share.

Smith-Midland Earnings Growth & SMID Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Smith-Midland Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):